QT_QuickTake

Market Quick Take - 2 October 2025

Macro 3 minutes to read
Saxo Be Invested
Saxo Strategy Team

Market Quick Take – 2 October 2025


Market drivers and catalysts

Equities: Wall Street extended gains as healthcare and big tech drove fresh records; Europe advanced with pharma strong and defence weaker; Asia opened higher after AI-chip strength lifted Korea and Hong Kong.
Volatility: VIX stays subdued as stocks notch fresh highs, but the US shutdown and today’s jobless claims keep event risk alive.
Digital Assets: Crypto holds firm into Europe’s open as ETF demand and a softer dollar backdrop support bitcoin and ether; majors trade steady.
Currencies: USD rebounds from ugly ADP payrolls dataCommodities: Gold resilient, crude slips on OPEC+ talk, soybeans caught in US-China standoff
Fixed Income: US yields drop sharply on ugly ADP payrolls data
Macro events: No US data due to government shutdown. Eurozone Unemployment

 

Macro headlines

  • The US Supreme Court's refusal to allow Trump to immediately oust Fed Governor Lisa Cook has eased pressure on the central bank after months of criticism from the White House. The order means Cook can remain at her post at least until the justices rule after hearing arguments in the case in January.
  • US manufacturing shrank for a seventh straight month in September as orders softened. The ISM factory index rose 0.4 points to 49.1, still signalling contraction and remaining stuck in a narrow range this year.
  • ADP said US private payrolls fell by 32,000 in September, after a revised 3,000 drop in August (vs. the original , missing all forecasts and partly reflecting data‑analysis issues. ADP periodically recalibrates to the Bureau of Labor Statistics series; the latest benchmark revision reduced September by 43,000 compared with pre‑benchmarked data.
  • The European Commission said it is planning on reducing foreign steel quotas by almost half and will increase tariffs by up to 50% on Chinese steel in line with US and Canadian partners.
  • Fitch Ratings stated the US government shutdown likely won't impact its sovereign rating soon, while S&P Global Ratings sees shutdowns as having minor economic effects. Fitch expects the deficit to narrow to 6.8% of GDP in 2025, boosted by $300 billion in tariff revenues. S&P cautions prolonged shutdowns could reduce GDP growth by 0.1%-0.2% weekly due to secondary effects.
  • The S&P Global Canada Manufacturing PMI fell to 47.7 in September 2025 from 48.3 in August, marking eight months of contraction due to US tariffs and Canada's retaliatory measures.
  • Euro area consumer inflation rose to 2.2% in September 2025, up from 2.0%, surpassing the ECB's 2.0% target. The rise was mainly due to a smaller energy cost decline of 0.4% compared to August's 2%. Services inflation increased to 3.2%, while food, alcohol, and tobacco inflation slowed to 3.0%. Non-energy goods inflation stayed at 0.8%. Core inflation remained stable at 2.3%.

 


Macro calendar highlights (times in GMT)

  • US economic data won’t be released due to government shutdown
  • 0900 – Eurozone Unemployment Rate
  • Markets closed in China for Golden Week Holiday

Earnings events

  • Today: Tesco PLC

For all macro, earnings, and dividend events check Saxo’s calendar.


Equities

  • USA: The S&P 500 rose 0.3% and the Nasdaq 100 0.5%, adding a fourth straight advance as investors looked past the federal shutdown and leaned into easing-labour data that support rate-cut expectations. Healthcare led on optimism around US drug-pricing talks, while megacap tech provided a steady tailwind; Treasuries rallied and gold set another record as the data blackout looms. Tesla and Nvidia were among notable gainers in the session’s tech bid, while the Dow finished little changed. Focus turns to private payroll and claims series in the absence of Friday’s official jobs report.
  • Europe: European equities closed broadly higher, with the Stoxx 600 up 1.2% as pharma outperformed and investors monitored the US shutdown’s data implications. AstraZeneca jumped 11.2% amid renewed listing chatter, Roche gained 8.6%, Novo Nordisk rose 6.4% and Zealand Pharma added 7.4%, while defence names lagged with Renk down 4.2% and Hensoldt off 3.0%. Euro-area inflation printed 2.2% year on year and UK house prices rose 2.2%, reinforcing the view that Europe’s disinflation continues even as growth remains patchy.
  • Asia: Asian equities rose in the prior session, led by Korea where Samsung climbed 4.5% and SK Hynix surged 11.0% on AI demand, while Hong Kong’s Hang Seng gained 1.5% and Australia’s ASX 200 added 1.3%. The upbeat tone carried into today’s open, with regional tech still in focus as investors weigh the spillover from AI-infrastructure momentum and prepare for US data delays during the shutdown.

Volatility

  • VIX closed at 16.3 as equities shrugged off Day 2 of the US government shutdown. The immediate driver is the data calendar: weekly jobless claims are still scheduled, but the broader shutdown raises the risk of a rolling “data blackout” that can amplify swings. A softer dollar and record-high gold temper stress for now. Options imply today’s S&P 500 move around ±1.0% (about ±69 points).

Digital Assets

  • Bitcoin trades near USD 118,500 and ether around USD 4,390 after mid-week gains, supported by shutdown-era dollar softness and steady risk appetite. US spot ETFs remain a strong tailwind, with IBIT and ETHA together drawing over USD 360m in fresh inflows across the last two sessions. Alt-coins are steady, with Solana holding in the low USD 220s and XRP near USD 3.

Fixed Income

  • US treasury yields dropped sharply yesterday on the release of the September ADP payrolls change report and steep negative revision to the August payrolls numbers as well as this points to higher likelihood of Fed easing and a slowing economy. The benchmark 2-year yield fell almost seven basis points to close at 3.54% as the market raised the likelihood of two more rate reductions this year and the benchmark 10-year yield fell five basis points to close at 4.10%.
  • Japan’s government bond yields were mostly steady near the highs of the cycle, with the benchmark 10-year trading this morning higher at 1.66%, which if maintained would be the highest daily close since 2008, but is not the highest intraday level which is a basis point higher. A 10-year JGB auction overnight saw weaker demand than the previous auction ahead of this Saturday’s LDP leadership vote that will determine the next Prime Minister.

Commodities

  • Brent crude slid to USD 65 after a three-day tumble, pressured by speculation OPEC+ could accelerate output hikes in November, alongside rising US crude inventories and US gasoline demand dropping to a six-month low. The alliance, which meets on Sunday, has denied such plans, but several major forecasters still expect an oversupplied market to drive prices lower in 2026.
  • Gold reached a fresh record on Wednesday, supported by US government shutdown jitters and renewed inflows at the start of the month, despite the absence of Chinese traders during the Golden Week holiday. While calls for consolidation are building, ETF demand remains strong, with 150 tons added since Powell’s dovish shift at Jackson Hole in August helping fuel the latest 16% rally.
  • Soybean futures rose after Trump pledged to confront Chinese President Xi Jinping at the upcoming Asia-Pacific Economic Cooperation summit over Beijing’s refusal to purchase US soybeans. Pressure is mounting on Republican Senators as farmers struggle, while data shows China had not booked a single cargo as of September 18—a first in records dating back to 1999.

Currencies

  • The US dollar weakened sharply yesterday on the back of the weak ADP payrolls data, but managed to bounce back from new local lows. EURUSD traded as high as 1.1779 before dropping back to as low as 1.1716, trading 1.1736 this morning in Europe. USDJPY bounced back from its steep slide to as low as 146.60 to trade back above 147.00 by later in the session, trading 147.17 this morning in Europe.
This content is marketing material and should not be regarded as investment advice. Trading financial instruments carries risks and historic performance is not a guarantee of future results.
The instrument(s) referenced in this content may be issued by a partner, from whom Saxo receives promotional fees, payment or retrocessions. While Saxo may receive compensation from these partnerships, all content is created with the aim of providing clients with valuable information and options..

Quarterly Outlook

01 /

  • Q4 Outlook for Investors: Diversify like it’s 2025 – don’t fall for déjà vu

    Quarterly Outlook

    Q4 Outlook for Investors: Diversify like it’s 2025 – don’t fall for déjà vu

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Q4 Outlook for Traders: The Fed is back in easing mode. Is this time different?

    Quarterly Outlook

    Q4 Outlook for Traders: The Fed is back in easing mode. Is this time different?

    John J. Hardy

    Global Head of Macro Strategy

    The Fed launched a new easing cycle in late Q3. Will this cycle now play out like 2000 or 2007?
  • Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Quarterly Outlook

    Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    Quarterly Outlook

    Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    John J. Hardy

    Global Head of Macro Strategy

    After the chaos of Q2, the quarter ahead should get a bit more clarity on how Trump 2.0 is impacting...
  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details. Past Performance is not indicative of future results.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992